AgingResearch.NewsJoin free

Recombinant human CD109

Intervention

1 paper1 finding

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

  • 1 lab in 1 country
  • Funders: Korea Health Industry Development Institute and 2 more
  • Cells1

Outcomes

1

KSHV infection

downin human cells1

1 study

  1. Recombinant human CD109 inhibits KSHV infection in human cells.

    “recombinant CD109 protein exhibiting inhibitory activity of KSHV infection by blocking virion binding.”

    Cellsrecombinant protein

    Senescence of endothelial cells increases susceptibility to Kaposi's sarcoma-associated herpesvirus infection via CD109-mediated viral entry

    The Journal of clinical investigationDec 12, 2024

More on KSHV infection

Latest

Related